Entry |
|
Name |
Neomycin sulfate (USP); Fradiomycin sulfate (JP18); Mycifradin (TN); Neo-fradin (TN); Sofratulle (TN) |
Product |
|
Generic |
|
Class |
Antibacterial
DG01447 Aminoglycoside antibiotic
|
Remark |
Product (DG00003): | D01618<JP/US> |
Product (mixture): | D02139<US> D02531<US> D04246<JP> D04250<JP> D04699<JP> D04753<JP> D04755<JP> D04795<JP/US> D04796<JP> D04806<JP> D11096<US> D11177<US> D11855<US> D12134<US> D12135<US> |
|
Efficacy |
Antibacterial, Protein biosynthesis inhibitor |
Target |
30S ribosomal subunit |
Pathway |
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A01 STOMATOLOGICAL PREPARATIONS
A01A STOMATOLOGICAL PREPARATIONS
A01AB Antiinfectives and antiseptics for local oral treatment
A01AB08 Neomycin
D01618 Neomycin sulfate (USP) <JP/US>
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07A INTESTINAL ANTIINFECTIVES
A07AA Antibiotics
A07AA01 Neomycin
D01618 Neomycin sulfate (USP) <JP/US>
B BLOOD AND BLOOD FORMING ORGANS
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B05C IRRIGATING SOLUTIONS
B05CA Antiinfectives
B05CA09 Neomycin
D01618 Neomycin sulfate (USP) <JP/US>
D DERMATOLOGICALS
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D06A ANTIBIOTICS FOR TOPICAL USE
D06AX Other antibiotics for topical use
D06AX04 Neomycin
D01618 Neomycin sulfate (USP) <JP/US>
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01G AMINOGLYCOSIDE ANTIBACTERIALS
J01GB Other aminoglycosides
J01GB05 Neomycin
D01618 Neomycin sulfate (USP) <JP/US>
R RESPIRATORY SYSTEM
R02 THROAT PREPARATIONS
R02A THROAT PREPARATIONS
R02AB Antibiotics
R02AB01 Neomycin
D01618 Neomycin sulfate (USP) <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AA Antibiotics
S01AA03 Neomycin
D01618 Neomycin sulfate (USP) <JP/US>
S02 OTOLOGICALS
S02A ANTIINFECTIVES
S02AA Antiinfectives
S02AA07 Neomycin
D01618 Neomycin sulfate (USP) <JP/US>
S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
S03A ANTIINFECTIVES
S03AA Antiinfectives
S03AA01 Neomycin
D01618 Neomycin sulfate (USP) <JP/US>
USP drug classification [BR:br08302]
Antibacterials
Aminoglycosides
Neomycin
D01618 Neomycin sulfate (USP)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
26 Epidermides
263 Suppurative dermatosis agents
2634 Antibiotics for external use
D01618 Neomycin sulfate (USP); Fradiomycin sulfate (JP18)
27 Dental preparations
276 Antibiotics
2760 Antibiotics
D01618 Neomycin sulfate (USP); Fradiomycin sulfate (JP18)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Fradiomycin
D01618 Neomycin sulfate (USP)
Drug groups [BR:br08330]
Antibacterial
DG01447 Aminoglycoside antibiotic
DG00003 Neomycin
D01618 Neomycin sulfate
Drug classes [BR:br08332]
Antibacterial
DG01447 Aminoglycoside antibiotic
D01618 Neomycin sulfate
Antimicrobials [BR:br08307]
Antibacterials
Protein biosynthesis inhibitor
Aminoglycoside
D01618 Neomycin sulfate (USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01618 Fradiomycin sulfate
Drug groups [BR:br08330]
Antibacterial
DG01447 Aminoglycoside antibiotic
DG00003 Neomycin
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Protein biosynthesis inhibitor
Aminoglycoside
DG00003 Neomycin
|
Other DBs |
|